BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9639867)

  • 1. Synthesis and A1 and A2A adenosine binding activity of some pyrano[2,3-c]pyrazol-4-ones.
    Colotta V; Catarzi D; Varano F; Melani F; Filacchioni G; Cecchi L; Trincavelli L; Martini C; Lucacchini A
    Farmaco; 1998 Mar; 53(3):189-96. PubMed ID: 9639867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines.
    Catarzi D; Cecchi L; Colotta V; Filacchioni G; Martini C; Tacchi P; Lucacchini A
    J Med Chem; 1995 Apr; 38(8):1330-6. PubMed ID: 7731018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
    Poulsen SA; Quinn RJ
    J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel adenosine receptor ligands: 1,3-disubstituted[1]benzopyrano[2,3-c]pyrazol-4-ones. Synthesis and structure-activity relationships.
    Colotta V; Cecchi L; Catarzi D; Melani F; Filacchioni G; Martini C; Tacchi P; Lucacchini A
    Recept Channels; 1993; 1(2):111-9. PubMed ID: 8081715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
    J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors.
    Dalpiaz A; Gessi S; Varani K; Borea PA
    Arzneimittelforschung; 1997 May; 47(5):591-4. PubMed ID: 9205770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands.
    Matuszczak B; Pekala E; Müller CE
    Arch Pharm (Weinheim); 1998 May; 331(5):163-9. PubMed ID: 9691247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
    Franchetti P; Cappellacci L; Marchetti S; Trincavelli L; Martini C; Mazzoni MR; Lucacchini A; Grifantini M
    J Med Chem; 1998 May; 41(10):1708-15. PubMed ID: 9572897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors.
    Vittori S; Camaioni E; Di Francesco E; Volpini R; Monopoli A; Dionisotti S; Ongini E; Cristalli G
    J Med Chem; 1996 Oct; 39(21):4211-7. PubMed ID: 8863798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives.
    Ferrarini PL; Mori C; Manera C; Martinelli A; Mori F; Saccomanni G; Barili PL; Betti L; Giannaccini G; Trincavelli L; Lucacchini A
    J Med Chem; 2000 Jul; 43(15):2814-23. PubMed ID: 10956189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
    Müller CE; Geis U; Hipp J; Schobert U; Frobenius W; Pawłowski M; Suzuki F; Sandoval-Ramírez J
    J Med Chem; 1997 Dec; 40(26):4396-405. PubMed ID: 9435909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists.
    Grahner B; Winiwarter S; Lanzner W; Müller CE
    J Med Chem; 1994 May; 37(10):1526-34. PubMed ID: 8182711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
    J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: a new class of selective A1 adenosine receptor antagonists.
    Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Novellino E; Greco G; Lavecchia A; Trincavelli L; Martini C
    J Med Chem; 2001 Feb; 44(3):316-27. PubMed ID: 11462973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
    Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
    J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo [4,3-alpha]-quinoxalin-1-one: a new A2A adenosine receptor antagonist with high selectivity versus A1 receptors.
    Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    Arch Pharm (Weinheim); 1999 Feb; 332(2):39-41. PubMed ID: 10233008
    [No Abstract]   [Full Text] [Related]  

  • 18. Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography.
    Todde S; Moresco RM; Simonelli P; Baraldi PG; Cacciari B; Spalluto G; Varani K; Monopoli A; Matarrese M; Carpinelli A; Magni F; Kienle MG; Fazio F
    J Med Chem; 2000 Nov; 43(23):4359-62. PubMed ID: 11087559
    [No Abstract]   [Full Text] [Related]  

  • 19. 2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes.
    Wanner MJ; Von Frijtag Drabbe Künzel JK; Ijzerman AP; Koomen GJ
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2141-4. PubMed ID: 10999489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
    J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.